Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-26 Sale | 2022-08-29 9:11 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 13,379 | $4.0105 | $53,656 | 908,778 (Indirect Direct) | View |
| 2022-05-26 Sale | 2022-05-27 5:34 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 13,162 | $1.9011 | $25,022 | 922,157 (Indirect Direct) | View |
| 2022-02-28 Sale | 2022-03-01 9:13 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 14,635 | $2.7795 | $40,678 | 935,319 (Indirect Direct) | View |
| 2021-11-26 Sale | 2021-11-29 7:46 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 27,747 | $4.8112 | $133,495 | 942,954 (Indirect Direct) | View |
| 2021-11-15 Purchase | 2021-11-15 5:59 pm | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 8,000 | $5.56 | $44,480 | 567,198 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Exercise | 2024-11-27 4:08 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2024-08-25 Exercise | 2024-09-12 6:13 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 7:50 pm | N/A 2034-06-20 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-05-25 Exercise | 2024-05-29 7:07 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2024-02-25 Exercise | 2024-02-27 7:58 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-11-25 Exercise | 2023-11-28 7:03 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-08-25 Exercise | 2023-08-29 6:52 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:34 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 7:32 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:30 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:18 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2022-07-08 Option Award | 2022-09-08 2:32 pm | N/A 2032-07-07 | BIOCEPT INC | BIOC | ROYSTON IVOR Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:11 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 25,219 | $0 | 908,778 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:34 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 25,219 | $0 | 922,157 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:32 pm | N/A 2032-03-17 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 412,500 | $0 | 412,500 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:13 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 25,219 | $0 | 935,319 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 6:47 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 7,000 | $0.9 | 657,688 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 6:47 pm | N/A 2029-02-13 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 7,000 | $0 | 657,688 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:46 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 50,437 | $0 | 942,954 (Direct) | View |
| 2021-07-16 Option Award | 2021-07-20 4:42 pm | N/A 2031-07-15 | BIOCEPT INC | BIOC | ROYSTON IVOR Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:03 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President | 441,993 | $0 | 441,993 (Direct) | View |
Ownership | 2021-02-24 7:31 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | VIRX | ROYSTON IVOR CEO & President | 0 | $0 | 1,232,252 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 2:25 pm | N/A 2030-06-04 | BIOCEPT INC | BIOC | ROYSTON IVOR Director | 500 | $0 | 500 (Direct) | View |